Video from AACC: Cytovale immune-response test for sepsis

By Leo O'Connor, Editor in Chief
July 29, 2022

Cytovale CEO Ajay Shah discusses unmet needs in the sepsis testing market and the firm’s 10-minute direct-from-blood IntelliSep test.

The San Francisco-based startup has submitted an application to the U.S. Food and Drug Administration (FDA) for clearance of the system and test, which aims to help emergency departments to more effectively and quickly triage patients.

Click on the video below for the interview.

Shah AACC interview
Cytovale CEO Ajay Shah.

Video from AACC: Thermo Fisher CMO on the future of diagnostics
Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with's...
Video from AACC: BrightInsight's Connected Diagnostics Platform
BrightInsight has launched the Connected Diagnostics Platform for the in vitro diagnostics manufacturer and the laboratory. The platform consists of four...
Video from AACC: Cloud-connected point-of-care diagnostics
Lonnie Adelman, CEO and founder of iAssay, and Dean Wong, investor and advisor to the firm, talked to (sister site of
Video from AACC: Reducing sequencing complexity
Clear Labs Chief Commercial Officer Jeff Field and Director of Assay Development Prasanna Thwar sat down with (sister site of
Video from AACC: Siemens Healthineers’ NAFLD test
Siemens Healthineers CMO Charles Cooper spoke to (sister site of about the firm’s Enhanced Liver Fibrosis...

Copyright © 2022

Last Updated lo 7/29/2022 10:09:33 AM